Search results for "Cannabinoid"

showing 3 items of 323 documents

WIN-induced vesiculation cooperates to the inhibition of osteosarcoma cell migration

2015

Introduction. Animal cells release vesicles that mediate the secretion of a variety of factors in the surrounding environment affecting neighboring cells. There is increasing evidence that secreted vesicles play an important role as vehicle of intercellular communication in different biological systems and are able to influence both physiological and pathological processes. Recently, we have reported that the synthetic cannabinoid WIN55,512 is able to induce osteosarcoma MG63 cell death and negatively affect cell migration. Here, we study the effects of WIN on the induction of vesicle secretion and their possible role in WIN-dependent reduction of osteosarcoma cell migratory ability. Method…

osteosarcomacannabinoids; osteosarcomacannabinoid
researchProduct

Synergistic effects induced by combinations of the synthetic cannabinoid WIN55,212-2 and the death receptor ligand TRAIL in hepatoma HepG2 cells.

2008

synergistic effectSettore BIO/10 - BiochimicaTRAILcannabinoid
researchProduct

The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols i…

2020

Background: Gilles de la Tourette syndrome (TS) is a chronic neuropsychiatric disorder characterized by motor and vocal tics. First-line treatments for tics are antipsychotics and tic-specific behavioral therapies. However, due to a lack of trained therapists and adverse events of antipsychotic medication many patients seek alternative treatment options including cannabis. Based on the favorable results obtained from case studies on different cannabis-based medicines as well as two small randomized controlled trials using delta-9-tetrahydrocannabinol (THC), we hypothesize that the cannabis extract nabiximols can be regarded as a promising new and safe treatment strategy in TS.Objective: To …

tourette syndromemedicine.medical_specialtyTHCTicslcsh:RC435-571NabiximolsPlacebo-controlled studynabiximolsPlaceboTourette syndromelaw.inventionStudy Protocol03 medical and health sciencescannabidioltetrahydrocannabinolcannabinoids0302 clinical medicineRandomized controlled triallawInternal medicinelcsh:Psychiatrymental disordersmedicinechronic tic disorderPsychiatrybusiness.industryticsnabiximols ; tetrahydrocannabinol ; cannabidiol ; chronic tic disorder ; tourette syndrome ; THC ; tics ; Tourette-Syndrom ; cannabinoidsmedicine.disease030227 psychiatryClinical trialPsychiatry and Mental healthChronic Tic Disorderbusiness030217 neurology & neurosurgerymedicine.drugFrontiers in Psychiatry
researchProduct